Quinolone resistance in Campylobacter [3]

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 3, 2003, Pages 740-742

  Greig, J R ^a  

^a ST HELIER HOSPITAL   (United Kingdom)

Author keywords

Campylobacter; Quinolone resistance; Travellers

Indexed keywords

CIPROFLOXACIN; ERYTHROMYCIN; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATION; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; GASTROENTERITIS; HUMAN; INFECTION RISK; LETTER; NONHUMAN; RISK ASSESSMENT; SENSITIVITY ANALYSIS; TRAVEL; UNITED KINGDOM;

4-QUINOLONES; ANTI-INFECTIVE AGENTS; CAMPYLOBACTER; CAMPYLOBACTER INFECTIONS; DRUG RESISTANCE, BACTERIAL; HUMANS;

EID: 0037342001     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg125     Document Type: Letter

References (4)

1. The Campylobacter Sentinel Surveillance Scheme Collaborators. (2002). Ciprofloxacin resistance in Campylobacter jejuni: case-case analysis as a tool for elucidating risks at home and abroad. Journal of Antimicrobial Chemotherapy 50, 561-8.
2. Gaunt, P. N. & Piddock, L. J. V. (1996). Ciprofloxacin resistant Campylobacter spp. in humans: an epidemiological and laboratory study. Journal of Antimicrobial Chemotherapy 37, 747-57.
3. Blaser, M. J. (2000). Campylobacter jejuni and related species. In Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases (Mandell, G. L., Bennett, J. E. & Dolin, R., Eds), pp. 2276-85. Churchill Livingstone, Philadelphia, PA, USA.
4. Engberg, J., Aarestrup, F. M., Taylor, D. E., Gerner-Smidt, P. & Nachamkin, I. (2001). Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerging Infectious Diseases 7, 24-34.